CAR-NK cells: A promising cellular immunotherapy for cancer
© 2020 The Author(s) Natural Killer (NK) cells and CD8+ cytotoxic T cells are two types of immune cells that can kill target cells through similar cytotoxic mechanisms. With the remarkable success of chimeric antigen receptor (CAR)-engineered T (CAR-T) cells for treating haematological malignancies,...
Main Authors: | Xie, Guozhu, Dong, Han, Liang, Yong, Ham, James Dongjoo, Rizwan, Romee, Chen, Jianzhu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier BV
2021
|
Online Access: | https://hdl.handle.net/1721.1/135407 |
Similar Items
-
CAR-NK cells: A promising cellular immunotherapy for cancer
by: Xie, Guozhu, et al.
Published: (2022) -
Memory-like NK cells armed with a neoepitope-specific CAR exhibit potent activity against NPM1 mutated acute myeloid leukemia
by: Dong, Han, et al.
Published: (2022) -
CAR-T cells targeting a nucleophosmin neoepitope exhibit potent specific activity in mouse models of acute myeloid leukaemia
by: Xie, Guozhu, et al.
Published: (2022) -
CAR-T cells targeting a nucleophosmin neoepitope exhibit potent specific activity in mouse models of acute myeloid leukaemia
by: Xie, Guozhu, et al.
Published: (2021) -
Ovarian Cancer Ascites Inhibits Transcriptional Activation of NK Cells Partly through CA125
by: Fraser, Christopher C, et al.
Published: (2023)